Exactech to Present at CanaccordAdams Annual Global Growth Conference on August 11
GAINESVILLE, Fla. -- August 10, 2009 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced that Chairman and CEO Bill Petty will present at the CanaccordAdams 29th Annual Global Growth Conference in Boston on Tuesday, August 11 at 4:30 p.m. Eastern Time.
GAINESVILLE, Fla. -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced that Chairman and CEO Bill Petty will present at the CanaccordAdams 29th Annual Global Growth Conference in Boston on Tuesday, August 11 at 4:30 p.m. Eastern Time.
CanaccordAdams 29th Annual Global Growth Conference is a premier forum for innovative small and mid-cap growth companies to present to and meet with institutional investors in emerging growth sectors. More than 240 small and mid-cap growth companies will be presenting at the conference.
A live and archived webcast of the presentation can be accessed via http://www.hawkassociates.com.
About Exactech
Based in Gainesville, Florida, Exactech
develops and markets orthopaedic implant devices, related surgical instruments
and biologic materials and services to hospitals and physicians. The company
manufactures many of its orthopaedic devices at its Gainesville facility.
Exactech’s orthopaedic products are used in the restoration of bones and joints
that have deteriorated as a result of injury or diseases such as arthritis.
Exactech markets its products in the United States and Australia, in addition to
more than 30 markets in Europe, Asia and Latin America. Additional information
about Exactech, Inc. can be found at http://www.exac.com.
Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors is available at http://www.exac.com and http://www.hawkassociates.com.
An Exactech investment profile is online at http://www.hawkassociates.com/profile/exac.cfm.
Investors may contact Chief Financial Officer Jody Phillips at 352-377-1140 or Julie Marshall or Frank Hawkins, Hawk Associates at 305.451.1888, e-mail: exactech@hawkassociates.com. To receive e-mail alerts about EXAC, sign up at http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.
